167 related articles for article (PubMed ID: 27217103)
21. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist.
Papp M; Gruca P; Willner P
Neuropsychopharmacology; 2002 Nov; 27(5):727-43. PubMed ID: 12431848
[TBL] [Abstract][Full Text] [Related]
22. Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats.
Yonghui L; Xigeng Z; Yunjing B; Xiaoyan Y; Nan S
J Psychopharmacol; 2006 Jan; 20(1):40-6. PubMed ID: 16174676
[TBL] [Abstract][Full Text] [Related]
23. Role of the NO/sGC/PKG signaling pathway of hippocampal CA1 in morphine-induced reward memory.
Shen F; Li YJ; Shou XJ; Cui CL
Neurobiol Learn Mem; 2012 Sep; 98(2):130-8. PubMed ID: 22820534
[TBL] [Abstract][Full Text] [Related]
24. The role of NMDA glutamate receptors in the lateral habenula on morphine-induced conditioned place preference in rats.
Amohashemi E; Reisi P; Alaei H
Synapse; 2023 Sep; 77(5):30-41. PubMed ID: 37122079
[TBL] [Abstract][Full Text] [Related]
25. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core.
Kobrin KL; Arena DT; Heinrichs SC; Nguyen OH; Kaplan GB
Behav Brain Res; 2017 Mar; 322(Pt A):18-28. PubMed ID: 28089852
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
28. Glutamate transporter type 3 participates in maintaining morphine-induced conditioned place preference.
Wan L; Bi J; Li J; Zuo Z
Neuroscience; 2017 Mar; 344():67-73. PubMed ID: 28049029
[TBL] [Abstract][Full Text] [Related]
29. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study.
Kao JH; Huang EY; Tao PL
Drug Alcohol Depend; 2011 Nov; 118(2-3):366-74. PubMed ID: 21601998
[TBL] [Abstract][Full Text] [Related]
30. Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference.
Narita M; Aoki T; Suzuki T
Neuroscience; 2000; 101(3):601-6. PubMed ID: 11113309
[TBL] [Abstract][Full Text] [Related]
31. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of muscarinic M1 receptors by dicyclomine inhibits the consolidation of morphine-associated contextual memory.
Esmaeili B; Basseda Z; Dehpour AR
Brain Res Bull; 2008 Jul; 76(4):380-7. PubMed ID: 18502314
[TBL] [Abstract][Full Text] [Related]
33. Effects of scopolamine and ketamine on reconsolidation of morphine conditioned place preference in rats.
Zhai H; Wu P; Chen S; Li F; Liu Y; Lu L
Behav Pharmacol; 2008 May; 19(3):211-6. PubMed ID: 18469538
[TBL] [Abstract][Full Text] [Related]
34. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Sakoori K; Murphy NP
Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
[TBL] [Abstract][Full Text] [Related]
35. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.
Rünkorg K; Veraksits A; Kurrikoff K; Luuk H; Raud S; Abramov U; Matsui T; Bourin M; Kõks S; Vasar E
Behav Brain Res; 2003 Sep; 144(1-2):125-35. PubMed ID: 12946603
[TBL] [Abstract][Full Text] [Related]
36. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement.
Ma YY; Chu NN; Guo CY; Han JS; Cui CL
Exp Neurol; 2007 Feb; 203(2):309-19. PubMed ID: 17014848
[TBL] [Abstract][Full Text] [Related]
37. Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation.
Rosen LG; Rushlow WJ; Laviolette SR
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):59-66. PubMed ID: 28627448
[TBL] [Abstract][Full Text] [Related]
38. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.
Yusoff NHM; Mansor SM; Müller CP; Hassan Z
Behav Brain Res; 2017 Aug; 332():1-6. PubMed ID: 28559179
[TBL] [Abstract][Full Text] [Related]
39. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories.
García-Pérez D; Ferenczi S; Kovács KJ; Laorden ML; Milanés MV; Núñez C
Mol Neurobiol; 2017 Oct; 54(8):6523-6541. PubMed ID: 27730515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
